Track topics on Twitter Track topics that are important to you
The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO of Roche has said, citing uncertainty over drug regulations and an unwillingness to use expensive branded drugs as potential turn-offs. Speaking to Reuters,...
Original Article: UK 'less interesting' to pharma because of Brexit - Roche CEONEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...